Results 31 to 40 of about 21,040,956 (164)

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.

open access: yesAmerican Journal of Psychiatry, 2013
OBJECTIVE The risk-benefit profile of antidepressant medications in bipolar disorder is controversial. When conclusive evidence is lacking, expert consensus can guide treatment decisions.
I. Pacchiarotti   +66 more
semanticscholar   +1 more source

Understanding the Current State of Play of Early Intervention for Bipolar Disorder: Qualitative Analysis of Consultations With International Stakeholders

open access: yesBipolar Disorders, Volume 28, Issue 2, March 2026.
ABSTRACT Background Despite the burden associated with bipolar disorder (BD), research into early diagnosis and treatment of BD lags approximately 20 years behind the field of early intervention for psychosis. This study evolved through a partnership between Orygen (Melbourne, Australia) and the Daymark Foundation (Toronto, Canada).
Sue M. Cotton   +12 more
wiley   +1 more source

Novine u standardu za obradu serijskih publikacija [PDF]

open access: yes, 2005
In the Paper, is given new information about ISBD (CR) - the International Standard Bibliographic Description for Serials and Other Continuing Resources update of the previous standard ISBD (S) - International Standard Bibliographic Description ...
Vukotić, Bojana
core  

A Cross‐Sectional Analysis of Social Determinants of Health in Bipolar Disorder: Exploring Gender‐Related Differences

open access: yesBipolar Disorders, Volume 27, Issue 8, Page 545-550, December 2025.
ABSTRACT Objectives To explore the clinical impact of social determinants of health (SDoH) stress in bipolar disorder (BD) course of illness and to explore potential gender differences in SDoH stress endorsement. Methods 2280 individuals living with BD type I or II (62% women; 67.5% BD‐I) participating in the Mayo Clinic Bipolar Biobank who completed a
Manuel Gardea‐Resendez   +19 more
wiley   +1 more source

An open reply to "What is going on at the Library of Congress?" by Thomas Mann [PDF]

open access: yes, 2006
This is an open response to a report by Thomas Mann at the Library of Congress concerning changes in cataloging. The author contends that, although the current changes at the Library of Congress are suspect, changes are imminent and experienced ...
Weinheimer, James
core  

Association Between Adherence Barriers, Self‐Reported Adherence, and Psychiatric Symptoms Among Adults With Bipolar Disorder

open access: yesBipolar Disorders, Volume 27, Issue 8, Page 567-577, December 2025.
ABSTRACT Aims While suboptimal medication adherence is a widely recognized problem for people with bipolar disorder (BD), it is less clear how individual characteristics are associated with varying levels of adherence and how specific adherence barriers impact behaviors.
Martha Sajatovic   +9 more
wiley   +1 more source

ISBD(CR) : prerađeno izdanje ISBD(S)-a

open access: yesVjesnik bibliotekara Hrvatske, 2004
U radu su prikazane razlike između ISBD(S)-a i njegova prerađenog izdanja, ISBD(CR)-a, objavljenog 2002. godine. Glavna je novina ISBD(CR)-a uvođenje pojma neomeđena građa, koji obuhvaća serijske publikacije i integrirajuću građu. Integrirajuća građa obuhvaća građu što se osuvremenjuje poput publikacija koje imaju uvez sa slobodnim listovima i mrežnih ...
Barbarić, Ana, Pigac, Sonja
openaire   +3 more sources

Do Patients Comply With 12‐h Lithium Blood Level Timing? Findings From a Controlled Clinical Trial and a Real‐World Clinical Setting

open access: yesBipolar Disorders, Volume 27, Issue 7, Page 519-526, November 2025.
ABSTRACT Background Lithium blood levels are measured routinely 12 h after lithium dosing, but no study has evaluated the actual compliance of patients with the 12‐h levels. Methods First, we used the US multicenter clinical trial “Bipolar CHOICE” (n = 145 patients treated with lithium with N = 287 lithium blood tests), where participants reported the ...
Søren L. Jacobsen   +4 more
wiley   +1 more source

Lithium Augmentation in Treatment‐Resistant Depression: A Qualitative Review of the Literature

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 688-701, October 2025.
ABSTRACT Depression is the leading cause of disability worldwide, affecting people of all ages. Both pharmacological and non‐pharmacological therapies are available for its treatment. However, some patients do not respond to first‐line pharmacological interventions, referred to as treatment‐resistant depression (TRD).
Angela Acero‐González   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy